[go: up one dir, main page]

NO168642C - Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 2-(formylamino)-n-(1h-tetrazol-5-yl)benzamid. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 2-(formylamino)-n-(1h-tetrazol-5-yl)benzamid.

Info

Publication number
NO168642C
NO168642C NO842968A NO842968A NO168642C NO 168642 C NO168642 C NO 168642C NO 842968 A NO842968 A NO 842968A NO 842968 A NO842968 A NO 842968A NO 168642 C NO168642 C NO 168642C
Authority
NO
Norway
Prior art keywords
tetrazol
benzamide
formylamino
preparation
therapeutic active
Prior art date
Application number
NO842968A
Other languages
English (en)
Other versions
NO842968L (no
NO168642B (no
Inventor
Norton P Peet
Shyam Sunder
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO842968L publication Critical patent/NO842968L/no
Publication of NO168642B publication Critical patent/NO168642B/no
Publication of NO168642C publication Critical patent/NO168642C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • C07D257/06Five-membered rings with nitrogen atoms directly attached to the ring carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Materials For Photolithography (AREA)
  • Paints Or Removers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
NO842968A 1983-07-22 1984-07-20 Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 2-(formylamino)-n-(1h-tetrazol-5-yl)benzamid. NO168642C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/517,086 US4567193A (en) 1983-07-22 1983-07-22 2-(Formylamino)-N-(1H-tetrazol-5-yl)benzamide and use as anti-allergics

Publications (3)

Publication Number Publication Date
NO842968L NO842968L (no) 1985-01-23
NO168642B NO168642B (no) 1991-12-09
NO168642C true NO168642C (no) 1992-03-18

Family

ID=24058297

Family Applications (1)

Application Number Title Priority Date Filing Date
NO842968A NO168642C (no) 1983-07-22 1984-07-20 Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 2-(formylamino)-n-(1h-tetrazol-5-yl)benzamid.

Country Status (18)

Country Link
US (1) US4567193A (no)
EP (1) EP0132788B1 (no)
JP (1) JPS6042372A (no)
KR (1) KR890000663B1 (no)
AT (1) ATE31925T1 (no)
AU (1) AU564328B2 (no)
CA (1) CA1220210A (no)
DE (1) DE3468683D1 (no)
DK (1) DK159775C (no)
ES (1) ES534533A0 (no)
GR (1) GR82100B (no)
HU (1) HU191432B (no)
IE (1) IE57584B1 (no)
IL (1) IL72430A (no)
NO (1) NO168642C (no)
NZ (1) NZ208934A (no)
PT (1) PT78931B (no)
ZA (1) ZA845517B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879295A (en) * 1986-09-27 1989-11-07 Sawai Pharmaceutical Co., Ltd. N-tetrazolyl thiazolecarboxyamide derivatives and their use
EP0321115B1 (en) * 1987-12-14 1991-08-14 Sawai Pharmaceutical Co., Ltd. Carboxamide derivatives having tetrazole and thiazole rings and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561350A (en) * 1976-11-05 1980-02-20 May & Baker Ltd Benzamide derivatives
CH630619A5 (en) * 1978-01-01 1982-06-30 May & Baker Ltd New derivatives of N-(5-tetrazolyl)benzamide

Also Published As

Publication number Publication date
JPH0369347B2 (no) 1991-10-31
DK159775B (da) 1990-12-03
PT78931B (en) 1986-09-08
AU564328B2 (en) 1987-08-06
IL72430A0 (en) 1984-11-30
JPS6042372A (ja) 1985-03-06
DE3468683D1 (de) 1988-02-18
IE57584B1 (en) 1993-01-13
NO842968L (no) 1985-01-23
HUT34460A (en) 1985-03-28
HU191432B (en) 1987-02-27
ES8601164A1 (es) 1985-10-16
DK159775C (da) 1991-05-06
NO168642B (no) 1991-12-09
PT78931A (en) 1984-08-01
KR890000663B1 (ko) 1989-03-22
AU3052784A (en) 1985-01-24
ATE31925T1 (de) 1988-01-15
NZ208934A (en) 1987-01-23
CA1220210A (en) 1987-04-07
IE841893L (en) 1985-01-22
DK358484D0 (da) 1984-07-20
US4567193A (en) 1986-01-28
EP0132788B1 (en) 1988-01-13
ES534533A0 (es) 1985-10-16
ZA845517B (en) 1985-03-27
KR850001182A (ko) 1985-03-16
EP0132788A1 (en) 1985-02-13
IL72430A (en) 1987-11-30
DK358484A (da) 1985-01-23
GR82100B (no) 1984-12-13

Similar Documents

Publication Publication Date Title
NO895086L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
NO168353C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(2'-aminofenyl)-benzamidderivater
NO168303C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater
NO851695L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-heteroaryl-tiazol-derivater
SE8301008D0 (sv) Pyrrolacetic amide having antiinflammatory activity
NO171214C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridonkarboksylsyrederivater
NO167916C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater
NO157452C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt bispidinderivat.
NO883122L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
NO170976C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylbuten-syrederivater
NO169648C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater
NO168642C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 2-(formylamino)-n-(1h-tetrazol-5-yl)benzamid.
NO169835C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive katecholkarboksylderivater
NO170930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-okso-3-kinolinkarboksylsyrer
NO913644D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO165999C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive n-(2-aminoetyl)benzamid-derivater.
NO168825C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-pyrrolidinyltio-1-azabicyklo (3.2.0) hept-2-en-2-karboksylsyrederivater
NO168641C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive carbamater og oxalamider av amino-n-(1h-tetrazol-5-yl)benzamider.
NO154091C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylaminoimidazolin-derivater.
NO160576C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive karboksylsyrederivater.
GB2011887A (en) Antiallergic agent
DE3674060D1 (de) Pharmacologisch aktive propionylanilide.
NO166410C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-piperazinkarboksamidderivater.
NO870499L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
FI882863A (fi) Foerfarande foer framstaellning av substituerade imidazo (1,5-a) pyridinderivat.